CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Biotech Startup

nanobio

NanoBio In RSV Vaccine Research Effort With Merck

Nanobio Corp. Thursday announced a preclinical collaboration with a subsidiary of Merck & Co. Inc. focused on the development of a vaccine for Respiratory Syncytial Virus (RSV).

WWJ Newsradio 950–12/08/2011

Follow

Get every new post delivered to your Inbox.

Join 1,885 other followers